Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0366220080430030179
Korean Journal of Hematology
2008 Volume.43 No. 3 p.179 ~ p.183
A Case of Desensitization for Hemophilia B Inhibitor Patient with Anaphylaxis to FIX Concentrates
Park Young-Shil

Yoo Ki-Young
Abstract
Among the patients with hemophilia, 10¡­15% have hemophilia B, and 1¡­3% of the hemophilia B patients develop inhibitor to factor IX clotting activity. Allergic reactions to concentrates containing factor IX (FIX) are serious complications during the treatment of hemophilia B patients with inhibitor. Although treatment with recombinant activated factor VII (FVIIa) is generally recommended in these patients, it is limited by the agent¡¯s short half-life, a lack of experience with its use in this manner and the prohibitive cost. We report here on a case of a 9-year-old boy with severe hemophilia B with inhibitor and he had a history of anaphylaxis to FIX. The patient was successfully treated with a desensitization protocol with escalating doses of FIX in addition to administering premedications.
KEYWORD
Hemophilia B, Inhibitor, Anaphylaxis, Desensitization
FullTexts / Linksout information
   
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø